⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25547106 | 0.62 | — | — | |
| SCHEMBL27412886 | 0.62 | — | — | |
| SCHEMBL27847895 | 0.58 | — | — | |
| SCHEMBL16683896 | 0.43 | — | — | |
| SCHEMBL1668955 | 0.35 | — | — | |
| SCHEMBL14271690 | 0.27 | — | — | |
| SCHEMBL120273 | 0.27 | — | — | |
| SCHEMBL24059 | 0.27 | — | — | |
| SCHEMBL23201538 | 0.24 | — | — | |
| SCHEMBL6559802 | 0.24 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025352-A | Condensed heterocyclic compound, pharmaceutical composition and application thereof | 北京康辰药业股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20230312605-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | TENARX, INC. | 2023-10-05 | — | — | US | claimed |
| EP-2376491-B1 | PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS | CEPHALON INC (US) | 2015-03-04 | — | — | EP | claimed |
| EP-1608656-A2 | IMIDAZOTRIAZINE COMPOUNDS | SmithKline Beecham Corporation (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2004087652-A2 | IMIDAZOTRIAZINE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-10-14 | — | — | WO | claimed |
| EP-4415816-B1 | PYRROLO[2,1-F][1,2,4]TRIAZINES DERIVATIVES AS INHIBITORS OF DYRK1A | BIOSPLICE THERAPEUTICS INC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20250163063-A1 | INHIBITORS OF CDK4/6 KINASE | KHORA SPV 1, LLC | 2025-05-22 | — | — | US | disclosed |
| WO-2025024707-A1 | INHIBITORS OF CDK2/4/6 KINASE | KINNATE BIOPHARMA INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| US-20250002823-A1 | Compositions For Removing Photoresist And Etch Residue From A Substrate With Copper Corrosion Inhibitor And Uses Thereof | VERSUM MATERIALS US, LLC | 2025-01-02 | — | — | US | disclosed |
| EP-4416555-A1 | COMPOSITIONS FOR REMOVING PHOTORESIST AND ETCH RESIDUE FROM A SUBSTRATE WITH COPPER CORROSION INHIBITOR AND USES THEREOF | Versum Materials US, LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| CN-118401902-A | Composition with copper corrosion inhibitor for removing photoresist and etching residues from a substrate and use thereof | 弗萨姆材料美国有限责任公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2023207447-A1 | PYRROLO[2,3-D]PYRIMIDINE OR PYRAZOLO[3,4-D]PYRIMIDINE DERIVATIVE, AND USE THEREOF | 腾讯科技（深圳）有限公司 | 2023-11-02 | — | — | WO | disclosed |
| WO-2006033005-A2 | THROMBOPOIETIN RECEPTOR AGONISTS | PFIZER PRODUCTS INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1608656-A2 | IMIDAZOTRIAZINE COMPOUNDS | SmithKline Beecham Corporation (US) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004087652-A2 | IMIDAZOTRIAZINE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-10-14 | — | — | WO | disclosed |
| EP-0640595-B1 | SUBSTITUTED TERTIARY AMINO COMPOUND OR SALT THEREOF | YAMANOUCHI PHARMA CO LTD (JP) | 1999-03-24 | — | — | EP | disclosed |
| CN-1039228-C | Novel substituted tert-amino compund | YAMANOUCHI PHARMA CO LTD (JP) | 1998-07-22 | — | — | CN | disclosed |
| US-5538976-A | ANTICARCINOGENIC AGENTS AND ENZYME INHIBITORS FOR AROMATASE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1996-07-23 | — | — | US | disclosed |
| EP-0640595-A1 | NOVEL SUBSTITUTED TERTIARY AMINO COMPOUND OR SALT THEREOF | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1995-03-01 | — | — | EP | disclosed |
| CN-1079962-A | New substituted tertiary amine compound and salt thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1993-12-29 | — | — | CN | disclosed |